![]() |
Re: Coronavirus
Quote:
The reality of Brexit will provide other examples such as this one which will ultimately get many more remainers on board with the whole idea of our new relationship with the EU, as the hard liners increasingly try to defend the indefensible. |
Re: Coronavirus
Quote:
https://www.lloydsloadinglist.com/fr...m#.YBk1tFjgphE |
Re: Coronavirus
@jonbxx
Another one for you, Jon. This is about CV mutations having regard for the Kent and SA variants. AXIOM A person has been vaccinated and antibodies are ready to work. HYPOTHESIS Let's say that this person comes into transmitted contact with someone carrying the SA variant and that the vaccinated person is now a carrier further spreading the virus. Now, the carried virus is doing battle with the antibodies and mutates in a manner that can defeat the antibodies. Is that right? If so, we are right up shit creek if the Guvmin doesn't curtail international arrivals. |
Re: Coronavirus
Quote:
Transference by surface contacts is another matter. |
Re: Coronavirus
More good news in the global battle against Covid.
Quote:
---------- Post added at 13:19 ---------- Previous post was at 12:53 ---------- Poland will only deploy the Oxford/AstraZeneca vaccine on 18- to 60-year-olds, Michael Dworczyk, the top aide to the prime minister said, on the advice of the country's Medical Council. Germany's vaccine committee, STIKO, has issued the same advice. |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
The second thing antibodies can do is block the virus. If the antibody binds to the 'Receptor Binding Domain' (RBD) of the virus, this will stop the virus getting in to cells and stop any infection. This is why mutations to the RBD are worrying as you could lose this neutralising' effect. You see names of mutations which have a letter, three numbers and another letter. This tells you what part of the protein has changed and what to. TECHY BIT - So the 'UK mutation' N501Y changes an asparagine amino acid at position 501 to a tyrosine. Anything in positions roughly 319 to 541 is worrying as you could lose that blocking effect. The South African variant has changes at 417, 484 and 501 which could be fun! Worst case is that a vaccinated individual antibodies won't recognise the variants at all but data so far shows that does seem to be the case. Even if you lost the neutralising effect completely, there will be antibodies against other bits of the spike as some bits are more variable than others. What seems to be seen is a lower response and this needs to be looked at with care. When your immune system is activated, you have a LOT of antibodies and T-cells up and running. It would be like being hit in the head with a 15lb or a 20lb sledgehammer - 25% less weight but still going to do you in |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
There will always be contention between Member States. |
Re: Coronavirus
Quote:
Their regulation wasn't legal in the first place. They can't invoke article 16 until a situation and it's effects, actually occur and are ongoing. They also have to tell the Joint Committee and the UK beforehand, and give one month's notice. They are not allowed to invoke it on the basis of a purely theoretical and unlikely risk. |
Re: Coronavirus
Quote:
So the simple answer to my question is: The CV arriving at "the person" will not mutate as a result of meeting the antibodies nor will that person be infectious. Have I got it? |
Re: Coronavirus
Quote:
|
Re: Coronavirus
RIP Sir Tom.
Quote:
|
Re: Coronavirus
Quote:
I’ll note we are somewhat digressing from topic and happy to leave the EU aside. |
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Merkel is backing VDL's approach.
https://www.dailymail.co.uk/news/art...-shambles.html Quote:
|
Re: Coronavirus
Quote:
Now what can happen is if you get infected and the virus can reproduce. Then you have a race between the immune system and virus reproduction. If you are vaccinated, then your immune system has a 'head start'. This will reduce or eliminate the amount of reproduction the virus can do before the immune system wipes it out. If during reproduction, a mutation occurs, then the fun can start. If you have a million virus without a mutation that allows it to avoid the immune system and one virion that does, then that million will be wiped out and the one will reproduce. Natural selection in action... |
Re: Coronavirus
Quote:
The Commission is the executive arm reporting to both the Council (of 27 nations) and the European Parliament. You've written nonsense, |
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Quote:
|
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Quote:
|
Re: Coronavirus
Quote:
Without the executive arm (as you correctly identify it) it’d merely be a talking shop. Policy decisions would outright be taken by a vote of leaders/Ministers of Member States (Council) or the Parliament. It’d lack its own identity. |
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Quote:
|
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Germany, Poland and now France restrict the upper age limit for the Oxford-AstraZeneca vaccine.
Quote:
|
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Quote:
While I’m sceptical of the real world performance of the AZ vaccine on the ground - and I think we can see Government are particularly concerned that 62% reduced by the 1 dose strategy doesn’t give much headroom against the new UK/SA hybrid variant - my cynicism goes in all directions. I wonder if the Sputnik V vaccine at 92% will push the Government to revisit it’s strategy and go for the half dose/full dose AZ that discovered highest results by accident - I think Sputnik V does the same low then high dose. |
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
RIP Sir Tom.
As China is the world's second largest economy, you'd think that the other countries affected by covid would sue them. It may not be possible to sue them for bringing the virus into the human food chain if it is their culture to eat such things, but they certainly made the situation much worse by initially trying to keep it quiet. |
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Quote:
It is a strange decision really, and hard to understand unless they think the quantities of the various vaccines they expect to receive mean they won’t end up leaving their most vulnerable citizens waiting longer, with the attendant risk, before they get any kind of vaccine at all. I’m curious though, whether your scepticism is based on a deeper understanding of the science, or just general cynicism? |
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Quote:
All other trials are finding that results against UK and SA variants are lower so unless we have a case of British exceptionalism I’d expect 62% to drop on the basis of one dose and drop against new mutations. To what degree is unknown. Watching the Government spring into action like I’ve never seen it before with door to door testing makes me naturally wonder what do they know that I don’t? |
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Quote:
Quote:
|
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Quote:
Furthermore I think you’re misunderstanding the words of advice from the vaccine manufacturers, none of whom have said “don’t change the dosage schedule” - what they have said is, “we have no data for that schedule” which is a bald, factual statement and exactly what you would expect from a scientist qualified only to report what their actual trial results are. In fact there is evidence that the first dose of any of the approved Covid vaccines is sufficient to very significantly reduce the incidence of serious disease. This is the public health outcome the UK government is pursuing at the moment; the first aim is to stop people dying of it. The AZ CEO said as much last week, and endorsed the UK government strategy for both the Pfizer and AZ vaccines. Of course I’m aware you rejected that when it came up in discussion last week - that’s why I tend to be cynical about your profession of concern, and tend to ascribe it to cynicism yourself. I don’t think you’re engaging in good faith with data or genuine public health policy aims, and are instead taking the usual path of least resistance, which is to assume everyone involved is incompetent, on the take, covering their own backs, etc. ---------- Post added at 18:02 ---------- Previous post was at 17:55 ---------- Quote:
And of course the point about comparable vaccines is worth stressing again and again. UK government policy in this area is not being developed in an absolute vacuum. |
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Quote:
Rather than go round in circles for weeks I’m more than happy to just wait and see what happens as this should become clear in the near future and lockdown restrictions ease. If deaths and hospitalisations among the vaccinated age groups are eliminated or significantly reduced that will clearly vindicate the strategy. If not I’m sure there will be a new variant along to blame and restrictions continue while further rounds of vaccination are developed. |
Re: Coronavirus (R.I.P Captain Sir Tom Moore 1920-2021)
Quote:
Quote:
"Some researchers worry that our immune systems could respond to an adenovirus vaccine by making antibodies against it, which would render a second dose ineffective. To avoid this, the Russian researchers used one type of adenovirus, Ad26, for the first dose, and another, Ad5, for the second." https://www.nytimes.com/interactive/...9-vaccine.html |
Re: Coronavirus
I think if a vaccine manufacturer had a choice of testing at 3 weeks or 12 weeks gap between doses, given the emergency they were always likely to test the shorter one first. However, lack of evidence is not evidence of lack, and as I've said before we are not designing vaccines in a vacuum. There is lots of data from other vaccines that give us an idea how things *should* work, all being well.
And in this case, not only does prior experience suggest the Oxford vaccine *should* work well with a longer gap between doses, there is now direct evidence that it *does* - and that it may in fact work better. The BBC has now written up a story based on that Lancet pre-press paper: https://www.bbc.co.uk/news/health-55910964 Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Back on topic, please
|
Re: Coronavirus
You know, it’s fun to be able to see the last time any particular member viewed this thread. Because it means some of the loudest critics of British government policy around vaccine rollout, and serial doubters of the efficacy data for the Oxford-AstraZeneca vaccine in particular, have been on the forum and have viewed this thread since the new data began to get wide coverage this evening. Yet none of them has had anything to say about it. :scratch:
|
Re: Coronavirus
The proof in the pudding of the Pfizer jab, will be whether people get a second booster dose within the time frame and the effect of that on the variants.
I would not be surprised if yet another variant appears before a month is out. |
Re: Coronavirus
Quote:
We’d simply be dismissed for having the audacity to think that this Government would take short cuts to get out of the pandemic. Herd immunity, antibody testing, rapid testing and Operation Moonshot all strategies to shorten the pandemic in the hope we’d gain some economic benefit. You’ve made the point yourself that there are serial doubters. I’ll happily put myself in that category and to be honest no number of scientists mulling over the data and presenting it in a slightly different way is going to give me confidence given it could be presented as 62/70/90/95% by the company responsible for testing it themselves. The real world activity is ongoing now and against the active variants in the community. The only results that count. ---------- Post added at 08:21 ---------- Previous post was at 08:17 ---------- Quote:
|
Re: Coronavirus
I'm sure there are many variants out there but many will be unviable for the virus, make no change to the proteins due to redundancy in coding, make no relevant change, make a relevant change but no practical difference to infectivity/antibody response/severity of infection.
It's hard talking about virii as they aren't really alive so they can't really be thought of as mutating. Mutations occur because of errors in processing in host cells and if that results in a virus that infects better it will grow in the population. --- The issue with CV is that it's novel to the world. Think of the impact of European explorers taking disease to the New World and how that decimated local populations to whom it was novel. Once we've cycled around this virus for a bit I'd expect death rates to reduce as we build up "herd immunity". Although the virus can still pass around and infect we get used to the type of virus and hopefully it becomes like flu or cold and for most people a minor disease with vaccinations/boosters for more vulnerable. |
Re: Coronavirus
EU vaccine war: Belgium bans AstraZeneca for over-55s in Brussels jibe as UK stands alone
BELGIUM has advised against giving the Oxford/AstraZeneca vaccine to over-55s because of a lack of data about its efficacy. https://www.express.co.uk/news/polit...e-covid-latest |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
To reiterate - there is nothing new here. Oxford’s trial group was tilted towards younger test subjects. This was widely known from quite early on. The calculations the German regulator has done, and has published, are plain silly, and TBH they just look like an extension of the cack-handed smear campaign someone in the German government was obviously trying to perpetrate last week. It pays not to underestimate the scale of the PR crisis we have caused for the EU and most importantly for its principal member states by getting so far ahead with our vaccine campaign. We have shown them and the EU up and there is nothing they can do at present to catch up with us. All they can do is to try to create a scenario where we are wasting our effort and they can say it’s better to do it right than do it fast. Repeat until you’re blue in the face: this vaccine has not been developed in a vacuum. If it works (and it does), it can be expected to have certain characteristics. This is in part what gave the government confidence to press ahead with the longer dosage interval - a decision now backed by hard data. It is also what gives the necessary confidence to use it in older patients. Vaccine efficacy does not typically drop off a cliff in the way it would have to do for it to suddenly be so unsuitable to use in anyone over 65. And in the case of the Oxford-AstraZeneca vaccine, the antibody response data that does exist is typical for what would be expected from a vaccine working as hoped, and adds to the confidence that it is efficacious in that age group. But of course, if you choose instead to be taken in by smear campaigns designed by governments that are actually failing their citizens, and are actively attempting to misdirect them, rather than vaccinate them, that is your privilege. |
Re: Coronavirus
Quote:
I would have thought anyone with an ounce of common sense would see from the data that is exactly what happens. You must be vaccinated before midnight the day before your 65th birthday otherwise it's just a waste of time and it won't work. |
Re: Coronavirus
By “following the science” in quotation marks I also intended to use the term somewhat ironically.
Once you get into the grounds of modelling outcomes outside those in the actual trial science becomes somewhat selective. If you had a desired policy outcome (e.g. to bypass the hardest to reach patients and into mass vaccination centres) you could propose this under the cloak of “following the science”. Something we know the UK Government has done, at all times. When emerging data becomes available - and it will from the UK in either direction - “the science” can be amended accordingly. Other, politically unpalatable, vaccination models have proposed to start with age groups with greater social contacts than the elderly. This way such a strategy could be shoehorned in without actually saying it was your intent. |
Re: Coronavirus
1 Attachment(s)
Quote:
If there was nothing special about the >65 group, then the number of cases expected from 341 candidates would be 1.8. So, with the number given by AZ = 1, the only thing we can say is the sample size is insufficient to be meaningful. I think everybody agrees on that. So, any decision to exclude the >65s from getting the vaccine is a simple matter of judgement by the relevant authorities. My instinct is that the >65s will benefit because the number was 1 not 2! A proper layman, am I. |
Re: Coronavirus
Hopefully further research will confirm the efficacy of the single dose, but it was from a small sampling.
Quote:
https://www.thetimes.co.uk/article/s...b7562376d49159 |
Re: Coronavirus
Quote:
|
Re: Coronavirus
AstraZeneca believes it can produce a modified vaccine fully effective against variant-covid by the autumn.
https://www.bbc.co.uk/news/health-55917793 Quote:
---------- Post added at 14:15 ---------- Previous post was at 13:58 ---------- Quote:
The summary analysis at the foot of the Times article says thus: Quote:
|
Re: Coronavirus
Sorry if it came across that way - it wasn't intended to (which is why I started with "Hopefully further research will confirm the efficacy of the single dose").
I want these vaccines to work, but it's important it's based on science/appropriate risk management. I think they've done the right thing by giving a greater amount of people a reasonable level of resistance, rather than a smaller amount of people a greater resistance - but I would have hated to be the one making the call on that decision. |
Re: Coronavirus
Switzerland bans AstraZeneca vaccine for ALL citizens as Europe declares war on UK jab
https://www.express.co.uk/news/polit...cine-uk-latest The decision makes it the only country in Europe not to authorise doses of the Oxford-produced jab for use. The Swiss medical regulator claimed there was a lack of data to reach conclusions on the efficacy of the COVID-19 vaccine. Approval of the jab had been widely expected by many in Switzerland. |
Re: Coronavirus
Quote:
The release for vaccines for use by either the MHRA in the UK or EMA in the EU are being done under different frameworks. The UK has given the vaccines we're having now an 'Emergency Use Authorisation' (EUA) This is not an approval of the vaccine in the traditional sense but more of a 'go ahead but you're on your own' status during the COVID emergency. One day, if COVID is gone, the authorisation will be withdrawn. The EMA is working on a Conditional Marketing Authorisation (CMA) which is a step above an EUA in terms of the robustness of the data needed. CMAs can be converted to a full authorisation often quite easily. CMAs are time limited to 1 year. I think it's due to the lack of data that the vaccine isn't being recommended for older recipients rather than any firm reason to doubt safety or efficacy. Of course, the UK is currently generating a HUGE data set for over 65s right now which I am sure will be used to convert the various flavours of interim drug licencing into full licences |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Isn't that the point of countries having their own independent regulators - they have to feel that it meets their criteria, rather than just following others.
Pretty sure Europe hasn't declared a "war" on the British-Swedish jab, sounds like the Excess is trying to inflame passions. |
Re: Coronavirus
Quote:
Toning down the nationalist rhetoric and reading the FT analysis they added: Quote:
Also not specified is whether they have any and when they’d be due to get delivery. Otherwise there’s no rush. ---------- Post added at 16:15 ---------- Previous post was at 16:14 ---------- Quote:
|
Re: Coronavirus
Quote:
The confidence interval in the AZ data is entirely negative and that's because there is no range of results that could fall within the entirely negative interval. The 1/314 result of the study is of insufficient statistical significance. It seems to me as a layman in the epidemiology business that 1/314 is heading in the right direction. ---------- Post added at 16:28 ---------- Previous post was at 16:25 ---------- Quote:
The UK's approval is emergency and thus temporary. I'm guessing that Switzerland doesn't need to give emergency authorisation and would prefer, as a matter of principle, to give permanent approval subject to the study results they are awaiting. |
Re: Coronavirus
Quote:
The elephant in the room is the control group showing 1/319 against the 1/341 for the dosed group. I think there's something missing datawise. If this is the total of the submitted data to the EMA/EU countries, I can understand the reasoning for the stopping of doses for the elderly - why give it to them if it doesn't work and there are alternatives. Unfortunately, regulatory submissions are very much not public domain :td: |
Re: Coronavirus
https://www.ggd.amsterdam.nl/coronav...ten/spironose/
Quote:
|
Re: Coronavirus
Quote:
https://www.breathomix.com/science-technology/ |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
https://www.breathomix.com/covid-ademtest/ Quote:
|
Re: Coronavirus
Quote:
Quote:
Typical of the EU, moan like hell they are not getting the vaccine, then decide they dont want to give to a load of people anyway. :rolleyes: |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
100 million. But we also have ordered 300million further vaccines from other manufacturers. https://www.itv.com/news/2021-02-01/...more-than-400m So given we’ve ordered enough vaccines to immunise the nation several times over I think HMG are doing alright. Certainly we’re not constrained to the one vaccine. |
Re: Coronavirus
Quote:
As someone keen to get out of lockdown I’m sure you’d appreciate that even without elements of data, unless there was evidence that the vaccine was dangerous in it’s own right, even at lower efficacy it’d be better than doing nothing. However that may be to reduce the R number, rather than deliver a return to normal and “herd immunity” by the middle of June as I’ve seen claimed elsewhere. If (or when) this isn’t achieved higher performing or a newer version of the vaccine will be required although I take comfort that they say this is deliverable by Autumn. We will have well developed distribution chains that it shouldn’t take too long to deliver to the requisite number of the population beyond then. |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Have there been any other examples where a vaccine has actually been shown to be less effective in the over-65s? If not, then saying use in over-65s is not proven, is a bit flimsy. If there have been examples where a vaccine has been found to be less effective, then caution might make more sense.
|
Re: Coronavirus
I think their point is they dont have much in the way of examples/data at all.
Much the same was as they could not recommend it for pregnant women - not becasue it wont work, or is less effective, but simply because they had no data on it. To think it will suddenly become less effective on your 65th birthday is just random nonsense though. |
Re: Coronavirus
Quote:
Unless there is a further breakdown by age for the under 65s, it might be possible that it isn't effective eg on the over 50s. The 60-64 group might also be small compared to the 65+ group. |
Re: Coronavirus
Quote:
The older you get, the more your body wears out (he says we’ll all die of some form of cancer, if something else doesn’t get us - your body’s repair mechanisms make more and more faulty cells, rather than the good ones). Because of this, vaccines (and medications) can cause different reactions in older people than in those in younger age groups - this is why older people often need additional medications to counter-act some of the effects of taking medications which those younger than them don’t need. So, they like to confirm that medications/vaccines won’t cause adverse effects in older people, rather than assume it (which is why the cohort I was in for the Novavax vaccine was mainly 60+). |
Re: Coronavirus
Quote:
Clinical trial design is tough as you really want to remove 'confounding factors' - other issues with the subjects of the trial that might affect the results and the elderly may have lots of those. In all likelihood, the vaccines will be effective in the elderly and this is how the UK has approached things but for a formal acceptance of a drug on to the market this isn't enough, you need to prove it. |
Re: Coronavirus
I'm quite worried, atm I'm quite fit /don't take any medications and my immune system seems to work just fine, but the science seems to say that from June 22 [my 65 birthday] i'm going to become a doddering old fart a vulnerable old fogey, a drain on the NHS.........:(
|
Re: Coronavirus
Quote:
You are doomed! ;) |
Re: Coronavirus
Actually Jfman raised an interesting point the other day ... a useful side-effect of the decision not to use the Oxford vaccine on older people in many European countries has handed their governments a decent excuse to explain their limited supply and also to do what the statistics say you should, but human decency says you shouldn't, which is to give the vaccine to younger people, who have more life ahead of them, and leave the elderly to take their chances...
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
I know we shouldn't go by anecdotal evidence, but of the seven people over 80 I know across England, all have received the Pfizer vaccine.
Really putting it out there. It's obviously not a sufficient sample size to be meaningful. If this pattern did proves to be more widespread, it might be that delivery schedules mean that more over-80s are receiving the Pfizer vaccine than the AstraZeneca one anyway. |
Re: Coronavirus
Quote:
My own surgery gave Pfizer to the over-80s but are definitely giving AZ to the over 75s. |
Re: Coronavirus
Maybe the over 80's got Pfizer because that was what was available when they were called in?
|
Re: Coronavirus
The AZ vaccinations did not start until 2nd January whilst the Pzizer Vaccinations started in early December so many over 80s and those in that first group had the Pfizer jab as it was the only one available.
:D beaten to the line by tweetiepooh. :D |
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
It also applies the logic we did of using the 12 week window that it’s better to give more people some immunity than people than a small number of people strong immunity. It’s very easy to spin given the immediate confusion in the AZ trial results. |
Re: Coronavirus
Quote:
I had my Pfizer jab in late January because that was the vaccine that one of the large Surgeries was using as it had the necessary freezer to store that vaccine. The other Surgery hub in my area didn't have that capability so they used the AZ vaccine. It all depended in which postcode our actual Surgery was located where we ended up getting vaccinated. |
Re: Coronavirus
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582124/
This article explains the reduced immune system capability in elderly people. Apparently it is principally due to shrinkage of the Thymus. Quote:
|
Re: Coronavirus
Everyone I know has also been given Pfizer but it could just be a coincidence if there was any policy I am sure it would have leaked by now.
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
Quote:
In terms of being in the supply chain longer the leaked Scottish Government documents (assuming they get 10% of the vaccines as a proportion of population) puts 7 million of the Pfizer vaccine in the supply to date. The AZ vaccine gets there this week, rising from 800 000 total supply in week commencing 11th January. I don't know how long it takes from delivery to arm but it's extremely likely anyone vaccinated before 18th January had the Pfizer one, on a sliding scale to next week where it should become about a 50/50 across everyone vaccinated to date. |
Re: Coronavirus
I tried to see which vials were being used in the package broadcast on the BBC news at 10 last night. The only bottle I could read a label on was an AstraZeneca one, so it’s definitely out there, although of course it’s impossible to say anything more about it than that.
|
Re: Coronavirus
Quote:
|
Re: Coronavirus
My dads first jab was the pfizer jab on the 14th
|
Re: Coronavirus
Someone I know had to fill in a form to book their appointment and it gave them the choice if which one to take which I thought was odd for both medical reasons (why give people the choice?) and logistically too. However, when they turned up they were only offering Pfizer anyway.
|
Re: Coronavirus
https://www.skysports.com/share/12208376
Suppose it’s easy to fudge the numbers if you let anyone passing by the mass vaccination site jump the queue. |
Re: Coronavirus
Quote:
It’s bad PR though, and if that’s what is happening then some effort must be made to regulate it so someone other than the fittest in society gets to ‘jump’ the queue. |
All times are GMT +1. The time now is 04:06. |
Powered by vBulletin® Version 3.8.11
Copyright ©2000 - 2025, vBulletin Solutions Inc.
All Posts and Content are © Cable Forum